Related Experiment Video

Updated: Jun 6, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

Catecholamine storage vesicles: role of core protein genetic polymorphisms in hypertension

Kuixing Zhang1, Yuqing Chen, Gen Wen

  • 1Department of Medicine and Institute for Genomic Medicine (IGM), University of California at San Diego School of Medicine, 9500 Gilman Drive, La Jolla, CA 92093-0838, USA.

Current Hypertension Reports
|November 25, 2010
PubMed

Insights

Genetic variations in chromogranin proteins (granins) may influence hypertension risk. This study investigates how these genetic differences affect blood pressure regulation and heritability.

Area of Science:

  • Genetics
  • Cardiovascular Science
  • Neuroendocrinology

Background:

  • Hypertension is a complex cardiovascular trait linked to autonomic nervous system dysfunction.
  • The sympathoadrenal system regulates cardiac output and vascular tone.
  • Adrenal medulla chromaffin granules store high concentrations of granins, catecholamines, and other molecules.

Purpose of the Study:

  • To review human genetic variations in major granin genes (CHGA, CHGB, SCG2).
  • To investigate the impact of granin gene polymorphisms on blood pressure.
  • To assess the heritability of blood pressure and its association with extreme blood pressure values.

Main Methods:

  • Review of human genetic variation at loci encoding chromogranin A, B, and secretogranin II.
  • Analysis of the effects of these polymorphisms on blood pressure.
  • Utilizing twin studies for heritability assessment and extreme phenotype analysis for hypertension.

Main Results:

  • Identified human genetic variations in key granin genes.
  • Examined the influence of these genetic polymorphisms on blood pressure levels.
  • Assessed the contribution of granin genes to blood pressure heritability and hypertension.

Conclusions:

  • Granin proteins are co-stored and co-released with catecholamines, suggesting a role in cardiovascular regulation.
  • Human genetic variation in granin genes presents a potential avenue for understanding blood pressure control.
  • Further research into granin gene polymorphisms may elucidate mechanisms underlying hypertension.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Assessing Murine Resistance Artery Function Using Pressure Myography07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...